Flemming Wagner is the Chief Operating Officer of Aposave Pharmacy. Aposave is a licensed UK pharmacy located in downtown London that focuses on providing original, branded specialty medications worldwide at competitive prices through an efficient online marketplace. Specialty medications are those developed for conditions such as cancer, hepatitis C, HIV, multiple sclerosis, diabetes, and rheumatoid arthritis. Flemming started the company in 2014 with his father, Aposave CEO John Wagner, and brings over 50 years of experience in the pharmaceutical industry.
Flemming is also the CEO of Abacus Medicine and Medcomb, leading European distributors of medicine and supplements that are headquartered in Copenhagen, Denmark. Abacus had a 2014 turnover of $100 million and has been voted as one of the top 10 fastest growing companies in Scandinavia. Medcomb is the company responsible for DAY DOSE, the revolutionary new supplement concept taking the European market by storm. Flemming has his Executive MBA from Copenhagen Business School and gives back to his alma mater by teaching Strategy during select semesters.